Spyre Therapeutics, Inc. (SYRE) compared with its closest peers (IONS, ORKA, ARWR, TGTX, TVTX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Ionis Pharmaceuticals, Oruka Therapeutics, Arrowhead Pharmaceuticals, TG Therapeutics, Travere Therapeutics, Rhythm Pharmaceuticals, Crinetics Pharmaceuticals, Mirum Pharmaceuticals and Liquidia share Spyre Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Ionis Pharmaceuticals, Inc. (IONS) | $9.00B | — |
| Oruka Therapeutics, Inc. (ORKA) | $6.12B | — |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $11.71B | — |
| TG Therapeutics, Inc. (TGTX) | $8.25B | 18.7 |
| Travere Therapeutics, Inc. (TVTX) | $6.15B | — |
| Xencor, Inc. (XNCR) | $1.81B | — |
| Rhythm Pharmaceuticals, Inc. (RYTM) | $7.21B | — |
| Crinetics Pharmaceuticals, Inc. (CRNX) | $9.01B | — |
| Mirum Pharmaceuticals, Inc. (MIRM) | $6.38B | — |
| Liquidia Corporation (LQDA) | $5.97B | 43.1 |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
SYRE overview · SYRE earnings · SYRE financials · SYRE KPIs · SYRE documents · SYRE ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.